Skip to content
10-Q

Quarterly Report

Insight Molecular Diagnostics Inc. IMDX

0001193125-25-274266

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 28.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 32.03M sh
Shares Diluted Q3 2025 · Sep 30, 2025 29.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 13.71M sh
Shares Diluted Q3 2025 · Sep 30, 2024 11.62M sh
Capex Q3 2025 · Sep 30, 2025 $1.71M
Capex Q3 2025 · Sep 30, 2024 $302K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.64M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$15.34M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $18.69M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.64M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$9.2M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.1M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$12.27M
Stockholders Equity Q3 2025 · Sep 30, 2024 $9.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 $22.7M
Stockholders Equity Q3 2025 · Dec 31, 2023 $20.47M
Current Liabilities Q3 2025 · Sep 30, 2025 $7.66M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.28M
Total Liabilities Q3 2025 · Sep 30, 2025 $53.13M
Total Liabilities Q3 2025 · Dec 31, 2024 $47.36M
Current Assets Q3 2025 · Sep 30, 2025 $21.39M
Current Assets Q3 2025 · Dec 31, 2024 $11.76M
Total Assets Q3 2025 · Sep 30, 2025 $43.94M
Total Assets Q3 2025 · Dec 31, 2024 $35.08M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.34
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.91
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.98
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.36
Eps Basic Q3 2025 · Sep 30, 2025 −$0.34
Eps Basic Q3 2025 · Sep 30, 2025 −$0.91
Eps Basic Q3 2025 · Sep 30, 2024 −$0.98
Eps Basic Q3 2025 · Sep 30, 2024 −$2.36
Sga Expense Q3 2025 · Sep 30, 2025 $2.55M
Sga Expense Q3 2025 · Sep 30, 2025 $8.31M
Sga Expense Q3 2025 · Sep 30, 2024 $2.57M
Sga Expense Q3 2025 · Sep 30, 2024 $7.65M
Rd Expense Q3 2025 · Sep 30, 2025 $3.88M
Rd Expense Q3 2025 · Sep 30, 2025 $10.07M
Rd Expense Q3 2025 · Sep 30, 2024 $2.82M
Rd Expense Q3 2025 · Sep 30, 2024 $7.58M
Net Income Q3 2025 · Sep 30, 2025 −$10.85M
Net Income Q3 2025 · Sep 30, 2025 −$27.27M
Net Income Q3 2025 · Sep 30, 2024 −$13.49M
Net Income Q3 2025 · Sep 30, 2024 −$27.15M
Operating Income Q3 2025 · Sep 30, 2025 −$11.05M
Operating Income Q3 2025 · Sep 30, 2025 −$27.69M
Operating Income Q3 2025 · Sep 30, 2024 −$13.52M
Operating Income Q3 2025 · Sep 30, 2024 −$27.41M
Gross Profit Q3 2025 · Sep 30, 2025 $139K
Gross Profit Q3 2025 · Sep 30, 2025 $1.8M
Gross Profit Q3 2025 · Sep 30, 2024 $50K
Gross Profit Q3 2025 · Sep 30, 2024 $145K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $121K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.11M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $43K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $184K
Revenue Q3 2025 · Sep 30, 2025 $260K
Revenue Q3 2025 · Sep 30, 2025 $2.92M
Revenue Q3 2025 · Sep 30, 2024 $115K
Revenue Q3 2025 · Sep 30, 2024 $395K